• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维蛋白原在直肠癌术前放化疗中作为预测指标的作用。

The role of fibrinogen as a predictor in preoperative chemoradiation for rectal cancer.

作者信息

Lee Jong Hoon, Hyun Jong Hee, Kim Dae Yong, Yoo Byong Chul, Park Ji Won, Kim Sun Young, Chang Hee Jin, Kim Byung Chang, Kim Tae Hyun, Oh Jae Hwan, Sohn Dae Kyung

机构信息

Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang-si, Gyeonggi-do, Republic of Korea.

出版信息

Ann Surg Oncol. 2015 Jan;22(1):209-15. doi: 10.1245/s10434-014-3962-5. Epub 2014 Nov 11.

DOI:10.1245/s10434-014-3962-5
PMID:25384698
Abstract

BACKGROUND

To perform chemoradiotherapy (CRT) effectively, it is clinically beneficial to identify predictors of tumor response after CRT. This study examined the association between plasma fibrinogen level before preoperative CRT and tumor response in advanced rectal cancer.

METHODS

This was a retrospective study of 947 patients who received preoperative CRT followed by curative surgery for primary rectal cancer. We analyzed clinical factors that could be associated with pathologic tumor response in terms of downstaging (ypStage 0-I), primary tumor regression (ypT0-1), and complete response (ypT0N0).

RESULTS

Downstaging was observed in 366 patients (38.6%), primary tumor regression in 187 patients (19.7%) and complete response in 138 patients (14.6%). Multivariate analysis found that pre-CRT carcinoembryonic antigen (CEA) level, fibrinogen level, hemoglobin level, clinical T and N classification, distance from anal verge, and histologic grade were significant predictive factors for downstaging; CEA level, fibrinogen level, and N classification predicted primary tumor regression; CEA level, and fibrinogen level were predictive for complete response.

CONCLUSIONS

This study demonstrated that fibrinogen level was a significant predictor of pathologic tumor response after preoperative CRT.

摘要

背景

为有效实施放化疗(CRT),识别CRT后肿瘤反应的预测指标具有临床益处。本研究探讨了术前CRT前血浆纤维蛋白原水平与晚期直肠癌肿瘤反应之间的关联。

方法

这是一项对947例接受术前CRT并随后接受原发性直肠癌根治性手术的患者的回顾性研究。我们分析了在降期(yp分期0-I)、原发性肿瘤退缩(ypT0-1)和完全缓解(ypT0N0)方面可能与病理肿瘤反应相关的临床因素。

结果

366例患者(38.6%)出现降期,187例患者(19.7%)出现原发性肿瘤退缩,138例患者(14.6%)出现完全缓解。多因素分析发现,CRT前癌胚抗原(CEA)水平、纤维蛋白原水平、血红蛋白水平、临床T和N分类、距肛缘距离以及组织学分级是降期的显著预测因素;CEA水平、纤维蛋白原水平和N分类可预测原发性肿瘤退缩;CEA水平和纤维蛋白原水平可预测完全缓解。

结论

本研究表明,纤维蛋白原水平是术前CRT后病理肿瘤反应的重要预测指标。

相似文献

1
The role of fibrinogen as a predictor in preoperative chemoradiation for rectal cancer.纤维蛋白原在直肠癌术前放化疗中作为预测指标的作用。
Ann Surg Oncol. 2015 Jan;22(1):209-15. doi: 10.1245/s10434-014-3962-5. Epub 2014 Nov 11.
2
CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.CEA-预测直肠癌新辅助治疗后病理完全缓解的指标。
Dis Colon Rectum. 2013 Jul;56(7):859-68. doi: 10.1097/DCR.0b013e31828e5a72.
3
Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.血清癌胚抗原作为直肠癌术前放化疗反应的预测指标。
J Surg Oncol. 2006 Feb 1;93(2):145-50. doi: 10.1002/jso.20320.
4
Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.接受直肠癌术前放化疗患者的肿瘤反应及降期预测因素。
Cancer. 2007 May 1;109(9):1750-5. doi: 10.1002/cncr.22625.
5
Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer.磁共振体素测量的肿瘤体积减少率与直肠癌术前放化疗的病理肿瘤反应相关。
Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):164-71. doi: 10.1016/j.ijrobp.2009.07.1682. Epub 2009 Dec 11.
6
Reappraisal of pretreatment carcinoembryonic antigen in patients with rectal cancer receiving preoperative chemoradiotherapy.对接受术前放化疗的直肠癌患者治疗前癌胚抗原的重新评估。
Tumori. 2013 Jan-Feb;99(1):93-9. doi: 10.1177/030089161309900116.
7
Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer.预测直肠癌术前放化疗后病理肿瘤反应的临床参数。
Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1167-72. doi: 10.1016/j.ijrobp.2007.04.047.
8
Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.癌胚抗原作为接受术前放化疗及手术治疗的局部晚期直肠癌患者病理反应的预测指标及预后因素。
Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):810-7. doi: 10.1016/j.ijrobp.2008.08.057. Epub 2008 Dec 26.
9
Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.病理性淋巴结分类是术前放化疗和根治性切除治疗的直肠癌患者无病生存的最具鉴别力的预后因素。
Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1158-65. doi: 10.1016/j.ijrobp.2009.06.019. Epub 2009 Sep 30.
10
Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.术前放化疗和根治性切除治疗直肠癌患者的化疗前后 s-CEA 降低率的临床意义。
Ann Surg Oncol. 2011 Nov;18(12):3271-7. doi: 10.1245/s10434-011-1740-1. Epub 2011 May 3.

引用本文的文献

1
The prognostic and protective roles of heart-rate variability in glioblastoma: making GBM less vague.心率变异性在胶质母细胞瘤中的预后和保护作用:使胶质母细胞瘤不再那么模糊。
J Neurooncol. 2025 Aug;174(1):219-225. doi: 10.1007/s11060-025-05010-3. Epub 2025 Jun 12.
2
Refining surveillance strategies for hepatocellular carcinoma with microvascular invasion.优化肝细胞癌微血管侵犯的监测策略。
Hepatol Int. 2025 Jun 6. doi: 10.1007/s12072-025-10847-x.
3
Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors combined with chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis.
新辅助PD-1抑制剂或PD-L1抑制剂联合放化疗治疗局部晚期直肠癌的疗效和安全性:一项系统评价和荟萃分析
Front Pharmacol. 2025 May 16;16:1570467. doi: 10.3389/fphar.2025.1570467. eCollection 2025.
4
Fibrinogen and tumors.纤维蛋白原与肿瘤
Front Oncol. 2024 May 8;14:1393599. doi: 10.3389/fonc.2024.1393599. eCollection 2024.
5
The role of preoperative FPR and FAR in prognostic evaluation of stages II and III radical colorectal cancer: A single-center retrospective study.术前 FPR 和 FAR 在 II 期和 III 期直肠癌预后评估中的作用:一项单中心回顾性研究。
Medicine (Baltimore). 2024 May 17;103(20):e38145. doi: 10.1097/MD.0000000000038145.
6
Efficacy and safety of PD-1 blockade plus long-course chemoradiotherapy in locally advanced rectal cancer (NECTAR): a multi-center phase 2 study.PD-1阻断联合长疗程放化疗治疗局部晚期直肠癌的疗效和安全性(NECTAR):一项多中心2期研究
Signal Transduct Target Ther. 2024 Mar 11;9(1):56. doi: 10.1038/s41392-024-01762-y.
7
The "Watch and Wait" Method After Chemoradiotherapy for Rectal Cancer Requiring Abdominoperineal Resection.直肠癌腹会阴联合切除术后放化疗的“观察与等待”方法
Indian J Surg Oncol. 2023 Dec;14(4):765-772. doi: 10.1007/s13193-023-01831-8. Epub 2023 Oct 13.
8
The Crying Need for a Better Response Assessment in Rectal Cancer.直肠癌更优疗效评估工具的迫切需求
Curr Treat Options Oncol. 2023 Nov;24(11):1507-1523. doi: 10.1007/s11864-023-01125-9. Epub 2023 Sep 13.
9
Predicting Factors of Complete Pathological Response in Locally Advanced Rectal Cancer.局部进展期直肠癌完全病理缓解的预测因素
Middle East J Dig Dis. 2022 Oct;14(4):443-451. doi: 10.34172/mejdd.2022.306. Epub 2022 Oct 30.
10
Interim result of phase II, prospective, single-arm trial of long-course chemoradiotherapy combined with concurrent tislelizumab in locally advanced rectal cancer.局部晚期直肠癌长疗程放化疗联合替雷利珠单抗同期使用的前瞻性单臂II期试验中期结果
Front Oncol. 2023 Feb 2;13:1057947. doi: 10.3389/fonc.2023.1057947. eCollection 2023.